Hyperprogressive disease in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors

被引：0
|
作者：
Ayala de Miguel, P. [1 ]
Lopez Gallego, J. [2 ]
Gorospe Garcia, I. [2 ]
Illan Varella, A. [2 ]
Rivera Vargas, P. R. [2 ]
Posada Restrepo, A. [2 ]
Borrega Garcia, P. [2 ]
机构：
[1] Hosp San Pedro Alcantara, Med Oncol, Caceres, Spain
[2] Hosp San Pedro Alcantara, Clin Oncol, Caceres, Spain
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
70P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Hyperprogressive Disease in Advanced Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
    Lo Russo, G.
    Signorelli, D.
    Proto, C.
    Galli, G.
    Prelaj, A.
    Ferrara, R.
    Sommariva, M.
    Moro, M.
    Cancila, V.
    Ganzinelli, M.
    Brich, S.
    Sangaletti, S.
    Pruneri, G.
    Tripodo, C.
    Colombo, M. P.
    Rivoltini, L.
    Balsari, A.
    Sozzi, G.
    Boeri, M.
    Garassino, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S245 - S245
  • [2] Prediction model for hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitors
    Choi, Yong Jun
    Kim, Taehee
    Kim, Eun Young
    Lee, Sang Hoon
    Kwon, Do Sun
    Chang, Yoon Soo
    [J]. THORACIC CANCER, 2020, 11 (10) : 2793 - 2803
  • [3] Hyperprogressive disease during treatment with immune checkpoint inhibitors in patients with advanced non-small cell lung cancer (NSCLC).
    Ayala de Miguel, Pablo
    Lopez Gallego, Javier
    Gorospe Garcia, Itziar
    Rivera Vargas, Pablo Rene
    Posada Restrepo, Andrea
    Aires Machado, Jonathan
    Alonso Calderon, Ruben
    Rodriguez Garcia, Jose Manuel
    Ceballos, Eduardo
    Acero Caballero, Alfonso
    Illan Varella, Andrea
    Quintana Cortes, Laura
    Borrega Garcia, Pablo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Hyperprogressive disease in patients with advanced cancer treated with immune checkpoint inhibitors
    Sen, Gulin Alkan
    Oztas, Nihan Senturk
    Degerli, Ezgi
    Guliyev, Murad
    Can, Guenay
    Turna, Hande
    Ozguroglu, Mustafa
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2024,
  • [5] Patterns of Failure in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
    Chai, Rong
    Yin, Yipengchen
    Cai, Xuwei
    Fu, Xiaolong
    Zhang, Qin
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Immune checkpoint inhibitors in advanced non-small cell lung cancer
    Fabre, Elizabeth
    Pecuchet, Nicola
    Cadranel, Jacques
    [J]. BULLETIN DU CANCER, 2016, 103 : S138 - S143
  • [7] Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
    Assi, Hazem I.
    Kamphorst, Alice O.
    Moukalled, Nour M.
    Ramalingam, Suresh S.
    [J]. CANCER, 2018, 124 (02) : 248 - 261
  • [8] Hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitor therapy, fact or myth?
    Britt, Alec S.
    Huang, Caitlyn
    Huang, Chao H.
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] The incidence and predictive factors of hyperprogressive disease (HPD) in non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICI).
    Lee, Yeun Ho
    Kim, Hyeonseon
    Chung, Il-Young
    Song, Chiwoo
    Kim, Leeseul
    Choi, Horyun
    Kim, Jinah
    Oh, Youjin
    Lee, Grace Yujin
    Cho, Heayoon
    Chae, Young Kwang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [10] The incidence and risk factors of hyperprogressive disease(HPD) in non-small cell lung cancer(NSCLC) treated with immune checkpoint inhibitors(ICI)
    Kim, Hyeonseon
    Lee, Yeun Ho
    Song, Chiwoo
    Kim, Leeseul
    Kim, Min Jeong
    Choi, Horyun
    Kim, Jinah
    Chae, Young Kwang
    [J]. CANCER RESEARCH, 2022, 82 (12)
12345